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Abstract
Transgenic plants expressing a foreign gene are a suit-
able system for the production of relevant immunogens
in high amounts that can be used for the development of
a new generation of vaccines against a variety of infec-
tious diseases. In the present study, the expression of the
nucleocapsid (N) protein of hantavirus serotype Puu-
mala in tobacco and potato plants was investigated.
Transgenic tobacco and potato plants were generated
and established. These transgenic plants expressed the
N protein of Puumala virus strain CG-1820. No major dif-
ferences were observed when the phenotype and
growth rates of transgenic plants were compared to
those of normal plants. However, it was found that the
leaves of transgenic tobacco plants were more slender
and the tubers of transgenic potato plants were smaller
than those in normal plants. In order to investigate the
distribution of the expression of the foreign gene in
transgenic plants, the proteins of leaves and roots of the
individual transgenic tobacco and potato plants were
examined by Western blot analyses. It was found that all
transgenic tobacco and potato plants expressed the N
protein in the leaves, whereas transgenic potato plants
are able to significantly express the viral proteins also in
the tubers and roots. The antigens were expressed at a
level of 1 ng of protein/5 Ìg of dried leaves. The hantavi-
ral recombinant N proteins obtained from transgenic
tobacco and potato plants were able to elicit specific
humoral and mucosal immune responses when admin-
istered intraperitoneally or orally to rabbits and mice.
The expression of viral proteins in plants has two major
advantages compared to other expression systems: first-
ly, there is no risk of contamination with mammalian
viruses or other pathogens, and secondly, the produc-
tion of high amounts of antigens is cheap and therefore
of great economic interest.
Copyright © 2003 S. Karger AG, Basel
Introduction
Hantaviruses are negative-sense, single-stranded RNA
viruses [1] that belong to the Bunyaviridae family. Differ-
ent serotypes are etiologic agents of a number of diseases
with renal and/or pulmonary involvement, ranging from
the more benign nephropathia epidemica (lethality 0.1–
1%) through hemorrhagic fever with renal syndrome (le-
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thality 3–10%) to the hantavirus pulmonary syndrome
(lethality 150%). The individual hantavirus genotypes
are carried by specific rodent hosts. Infection of humans
occurs by aerosol inhalation of contaminated rodent ex-
cretions.
The three-segment genome of hantaviruses codes for
the viral RNA-dependent RNA polymerase (L-RNA seg-
ment), the glycoproteins G1 and G2 (M-RNA segment)
and the viral nucleocapsid protein (S-RNA segment). The
viral nucleocapsid protein is an important structural pro-
tein and is essential for packaging of the RNA segments
and encapsidation [2]. Major antigenic domains of han-
taviruses are also located on the nucleocapsid protein [3].
The early immune response is mainly directed against this
structural protein, and sera of convalescent patients pre-
dominantly contain antibodies against the nucleocapsid
protein [4–7]. Furthermore, the viral nucleocapsid pro-
teins, together with the viral glycoproteins G1 and G2, are
promising candidates for the development of new vacci-
nation strategies.
Recent studies have shown that proteins expressed in
plants are suitable tools for the production of antigens.
Bacterial toxins and various viral proteins have been suc-
cessfully expressed in plants and found to be immunogen-
ic [8–14].
These proteins were able to elicit specific humoral and
mucosal immune responses when administered intraperi-
toneally or orally to animals and to protect the animals
against the corresponding viral or bacterial infections.
The expression of viral proteins in plants has the follow-
ing advantages compared to other expression systems:
firstly, there is no risk of contamination with mammalian
viruses or other pathogens, and secondly, the production
of antigens based on expression of the proteins is cheap
and therefore of economic interest.
Materials and Methods
Transgenic Tobacco Plants
The transgenic tobacco plants were generated by transformation
of Nicotiana tabacum cv. SR1 plants as described previously [14].
Briefly, leaves of the plant were immersed in MS liquid medium con-
taining bacterial cells which harbored the recombinant binary plas-
mid pBinAR-PUU-S encoding the Puumala nucleocapsid (N) pro-
tein sequences. After 48 h, the leaves were washed with media con-
taining cefotaxime and plated on selective agar media which con-
tained kanamycin (100 Ìg/ml), cefotaxime (500 Ìg/ml), benzalade-
nine 2 Ìg/ml and naphthalene acetic acid 0.1 Ìg/ml. Putative trans-
formed shoots were further grown on kanamycin and analyzed for
the expression of Puumala N protein.
Transgenic Potato Plants
The transgenic potato plants were generated by transformation of
Solanum tuberosum cultivar Desiree tubers as described previously
[14]. Briefly, microtubers cut into 1- to 2-mm discs were inoculated
with bacterial cells which harbored the recombinant binary plasmid
pBinAR-PUU-S encoding the Puumala N protein sequences for 2–3
days. After cocultivation, the discs were washed with medium con-
taining cefotaxime (500 Ìg/ml). The discs were transferred onto MS
medium containing kanamycin (50 Ìg/ml), cefotaxime (300 Ìg/ml),
GA3 0.02 Ìg/ml and zeatin 2 Ìg/ml. Putative transformed shoots
were further grown on kanamycin and analyzed for the expression of
Puumala N protein [14].
Sera and Antibodies
Antiserum against recombinant N proteins of Puumala virus
strain CG-1820 was induced in New Zealand white rabbits. Recom-
binant N proteins were generated as described elsewhere [15, 16].
The rabbit antiserum against Puumala virus N protein was able to
detect 0.125 ng of recombinant viral N protein.
Immunoblot Analysis
Plant tissues, including leaves and roots, were harvested and
dried for 72 h at 50°. Samples of leaf tissue powder (200 Ìg) were
dissolved in lysis buffer [600 Ìl with 0.001 M Tris-HCl, 10% glycerol,
2% SDS, 5% ß-mercaptoethanol, 0.1% (w/v) bromophenol blue, pH
8] and heated for 5 min at 95°. The insoluble fraction was removed
by centrifugation at 17,000 g for 5 min. Proteins were separated by
SDS-PAGE and electroblotted on nitrocellulose filters. Transfer effi-
ciency was monitored by ponceau staining (Sigma, Munich, Germa-
ny). Filters were blocked for 1 h and incubated with a 1/1,000 dilu-
tion of rabbit antiserum. Peroxidase-conjugated antibodies were
used to detect interaction of the rabbit antiserum with hantaviral
proteins.
Results
Phenotypic Characterization of Transgenic Tobacco
Plants Expressing Puumala N Protein
Transgenic tobacco plants were grown in commercial
garden mould at room temperature. Under these condi-
tions, the growth rate of transgenic plants was comparable
to that of normal tobacco plants. They developed 2–4
leaves per week and grew to a final height of 1.2 m (fig. 1).
The growth rate did not differ from that of normal tobac-
co, but the final height of the normal plants was slightly
greater (1.5 m).
The leaves of transgenic tobacco plants were more
slender but just as long as normal tobacco leaves. No other
differences could be detected.
Phenotypic Characterization of Transgenic Potato
Plants Expressing Puumala N Protein
Transgenic potato plants were grown in commercial
garden mould at room temperature. Under these condi-
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Fig. 1. Transgenic tobacco plant expressing the N protein of Puumala virus CG-1820 (B) in comparison to a normal
tobacco plant (A). Both plants were cultured for 10 weeks under identical conditions. The photographs of both plants
were taken at the same scale.
Fig. 2. Transgenic potato plant expressing the N protein of Puumala virus CG-1820 after 3 months of cultivation.
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Fig. 3. Western blot analyses of proteins of
transgenic plants using rabbit antibodies
generated against recombinant Puumala vi-
rus N protein. A Distribution of the expres-
sion of Puumala N protein in the leaves of
transgenic tobacco (lanes 3–9) and transgen-
ic potato plants (lanes 10–15). Lane 1: mo-
lecular weight marker; lane 2: recombinant
N protein of Puumala virus (5 ng). The
arrow indicates the position of the Puumala
virus N protein. B Distribution of the ex-
pression of Puumala N protein in the leaves
and roots of two transgenic tobacco plants.
Lanes 1 and 2: protein extracts of the roots
(lane 1) and leaves (lane 2) of a transgenic
tobacco plant (NT-PUU-F4-1); lanes 3 and
4: protein extracts of the leaves (lane 3) and
roots (lane 4) of a second transgenic tobacco
plant (NT-PUU-F4-2); lane 5: recombinant
N protein of Puumala virus (5 ng); lane 6:
molecular weight marker. The arrow indi-
cates the position of the Puumala virus N
protein.
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tions, the growth rate of transgenic plants was comparable
to that of normal potato plants (fig. 2). They developed
4–6 leaves per week and grew to a final height of 0.8 m
(fig. 1). The growth rate did not differ from that of normal
potato plants, but the tubers were smaller (average weight
of transgenic tubers = 19.8 g, average weight of normal
tubers = 30.7 g) and the average number of tubers gener-
ated by each transgenic plant was smaller (average num-
ber of tubers per transgenic plant = 4.3, average number
of tubers per normal plant = 8.0). No other differences
could be detected.
Distribution of Expression of Puumala N Protein in
Transgenic Tobacco and Potato Plants
In order to investigate the distribution of the expres-
sion of Puumala N protein in two transgenic tobacco
plants, 200 Ìg of powdered leaves and roots were ana-
lyzed by Western blots. The proteins were separated by
SDS-PAGE and blotted onto nitrocellulose. As shown in
figure 3, the expression of Puumala N protein differed
between the two plants. In plant 1, expression could be
detected in the leaves and roots. In contrast, expression of
Puumala N protein in plant 2 could only be detected in
the leaves.
Similar experiments were performed using leaves and
tubers of transgenic potato plants. In all transgenic plants
which were examined (n = 6), expression of Puumala N
protein could be detected in the leaves and tubers. The
amount of expression of the protein was similar, i.e. no
major differences could be detected between the transgen-
ic potato plants (data not shown).
Stability of Expression of Puumala N Protein in
Different Generations of Transgenic Tobacco Plants
In order to investigate if the expression of Puumala N
protein is stable in different generations of transgenic
tobacco plants, the leaves of five generations (P, F1, F2,
F3 and F4) of plants were analyzed. As shown in figure 4,
no differences could be detected. The amount of Puumala
N protein expressed in the leaves of these plants was
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Fig. 4. Stability of expression of Puumala N protein in different gen-
erations of transgenic tobacco plants (P, F1, F2, F3 and F4). Lane 1:
recombinant N protein of Puumala virus (5 ng); lanes 2 and 3: sam-
ple buffer serving as negative control; lanes 4–8: protein extracts of
leaves of transgenic tobacco plants (lane 4: NT-PUU-P1; lane 5: NT-
PUU-F1-1; lane 6: NT-PUU-F2-1; lane 7: NT-PUU-F3-1; lane 8:
NT-PUU-F4-1). M = Molecular weight marker. The arrow indicates
the position of the Puumala virus N protein. A Western blot analyses
of proteins of transgenic plants using rabbit antibodies generated
against recombinant Puumala virus N protein. B Coomassie staining
of the SDS-PAGE.
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about the same in each generation. This indicates that
integration of the foreign DNA is stable, without any
selection pressure, and that the expression is not reduced
by silencing mechanisms, at least under the conditions
used here.
Discussion
Transgenic plants expressing foreign genes are a suit-
able system for the production of relevant immunogens in
high amounts that can be used for development of a new
generation of vaccines against a variety of infectious dis-
eases. In the present study, the expression of the N protein
of hantavirus serotype Puumala in tobacco and potato
plants was investigated.
The hantaviral recombinant N proteins obtained from
transgenic tobacco and potato plants have been shown to
be able to elicit specific humoral and mucosal immune
responses when administered intraperitoneally in rabbits
and mice [14]. Oral immunization of mice is under inves-
tigation. Only recently, it was shown that oral immuniza-
tion of mice with hepatitis B surface antigen expressed in
transgenic plants was successful [17]. Hence, the expres-
sion of hantaviral antigens in transgenic plants is a suit-
able approach for the development of a vaccine against
hantaviral infections. At present, there is no commercially
available hantaviral vaccine. The limiting factor is that it
is still not possible to express hantaviral glycoproteins
with high manufacturing efficiency. A variety of new gen-
erations of hantaviral vaccines are still at an experimental
stage [18–20].
The expression of viral proteins in plants has the fol-
lowing major advantages: firstly, there is no risk of con-
tamination with mammalian viruses or other pathogens,
and secondly, the production of high amounts of antigens
is cheap and therefore of great economic interest. The
possibility of antigen expression in high amounts facili-
tates the characterization of protein interactions in phar-
macokinetic studies and in addition enables basic science
on the further structural characterization of the viral anti-
gens by crystallization.
Finally, transgenic plants expressing hantaviral anti-
gens could be used for oral field immunizations of rodents
which serve as vectors, thereby eradicating the main path-
way of transmission of hantaviruses to humans.
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